Atria Investments LLC Bristol Myers Squibb CO Transaction History

Atria Investments LLC

$7.36 Billion
Q2 2024

A detailed history of Atria Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atria Investments LLC holds 116,947 shares of BMY stock, worth $6.22 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

116,947

Previous 138,838 15.77%

Holding current value

$6.22 Million

Previous $7.53 Million 35.5%

% of portfolio

0.07%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $881,112 - $1.16 Million	-21,891 Reduced 15.77%	116,947 $4.86 Million
Q1 2024 May 21, 2024	BUY	$47.98 - $54.4 $780,634 - $885,088	16,270 Added 13.27%	138,838 $7.53 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1.07 Million - $1.27 Million	-21,995 Reduced 15.21%	122,568 $6.29 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $909,799 - $1.02 Million	-15,716 Reduced 9.81%	144,563 $8.39 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $471,581 - $523,617	7,402 Added 4.84%	160,279 $10.2 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $1.31 Million - $1.48 Million	19,862 Added 14.93%	152,877 $10.6 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $9,655 - $11,433	-141 Reduced 0.11%	133,015 $9.57 Million
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $575 - $340,324	-4,429 Reduced 3.22%	133,156 $9.47 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $217,496 - $239,540	-2,995 Reduced 2.13%	137,585 $10.6 Million
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $1.61 Million - $1.93 Million	26,188 Added 22.89%	140,580 $10.3 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $1.01 Million - $1.17 Million	18,779 Added 19.64%	114,392 $7.13 Million
Q3 2021 Nov 16, 2021	BUY	$59.17 - $69.31 $172,421 - $201,969	2,914 Added 3.14%	95,613 $5.66 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $211,546 - $230,374	-3,417 Reduced 3.56%	92,699 $6.19 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $58,449 - $65,738	985 Added 1.04%	96,116 $6.07 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $952,017 - $1.08 Million	-16,488 Reduced 14.77%	95,131 $5.9 Million
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $1.09 Million - $1.21 Million	19,057 Added 20.59%	111,619 $6.73 Million
Q2 2020 Sep 22, 2020	BUY	$54.82 - $64.09 $5.07 Million - $5.93 Million	92,562 New	92,562 $5.44 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $7.47 Million - $10.9 Million	-161,017 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $5.53 Million - $7.22 Million	112,445 Added 231.5%	161,017 $10.3 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $228,776 - $271,247	-5,349 Reduced 9.92%	48,572 $2.46 Million
Q2 2019 Aug 26, 2019	BUY	$44.62 - $49.34 $2.41 Million - $2.66 Million	53,921 New	53,921 $2.51 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $1.56 Million - $1.73 Million	-34,973 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $376,030 - $448,369	8,334 Added 31.28%	34,973 $1.67 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $1.3 Million - $1.68 Million	-26,625 Reduced 49.99%	26,639 $1.39 Million
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $66,338 - $74,824	1,202 Added 2.31%	53,264 $3.31 Million
Q2 2018 Jul 13, 2018	SELL	$50.53 - $62.98 $35,522 - $44,274	-703 Reduced 1.33%	52,062 $2.88 Million
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $251,903 - $289,991	4,204 Added 8.66%	52,765 $3.34 Million
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $425,214 - $463,592	7,094 Added 17.11%	48,561 $2.98 Million
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $2.29 Million - $2.64 Million	41,467	41,467 $2.64 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Bristol Myers Squibb CO Transaction History